Skip to content
OpenCapital
Get started

Lifecore Biomedical, Inc. LFCR Reportable Segment — Income from Discontinued Ops

Similar metrics at other companies

Roivant Sciences logo
ROIVReportable Segment — Income from discontinued operations, net of tax
$0—
Inseego Corp. logo
INSGReportable Segment — Income (loss) from discontinued operations (net of income tax provision (benefit) of $— and $400, respectively)
$0+100%
ADT logo
ADTReportable Segment — Income (loss) from discontinued operations, net of tax
-$977K+56.2%
Consensus Cloud Solutions, Inc. logo
CCSIReportable Segment — Income from Continuing Ops
$24.69M+16.7%
SIFCO Industries logo
SIFReportable Segment — Income (loss) from continuing operations
$2.65M+301%
Valvoline logo
VVVReportable Segment — Income from Continuing Ops
$45.3M+18.3%

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M—
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M—
CapEx$1.1M-46.7%
Free cash flow$3.6M—

Valuation

See full
Market cap$196.92M-37.3%
Enterprise value$333.06M+6.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%—
FCF margin-36.4%—

Returns & leverage

See full
Return on equity-612.1%—
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity.

The official record: Lifecore Biomedical, Inc.’s 10-K, filed August 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s reportable segment — income from discontinued ops.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s reportable segment — income from discontinued ops?
Lifecore Biomedical, Inc. (LFCR) reported reportable segment — income from discontinued ops of $0 in Q1 2025.
How has Lifecore Biomedical, Inc.'s reportable segment — income from discontinued ops changed year-over-year?
Lifecore Biomedical, Inc.'s reportable segment — income from discontinued ops decreased by 100.0% year-over-year, from $670.5K to $0.
What does reportable segment — income from discontinued ops mean?
This metric reports the net earnings or losses generated by business units or product lines that the company has either disposed of or classified as held for sale. It isolates the financial impact of legacy operations that are no longer part of the company's ongoing strategic focus. Separating this income allows stakeholders to better assess the performance of the company's continuing operations without the distortion of divested assets.